- Home
- WORX vs XXII Comparison
WORX vs XXII Comparison
Compare WORX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- XXII
- Stock Information
- Founded
- WORX N/A
- XXII 1998
- Country
- WORX United States
- XXII United States
- Employees
- WORX N/A
- XXII N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- XXII Medicinal Chemicals and Botanical Products
- Sector
- WORX Consumer Discretionary
- XXII Health Care
- Exchange
- WORX Nasdaq
- XXII Nasdaq
- Market Cap
- WORX 2.5M
- XXII 2.0M
- IPO Year
- WORX N/A
- XXII N/A
- Fundamental
- Price
- WORX $0.31
- XXII $1.72
- Analyst Decision
- WORX
- XXII
- Analyst Count
- WORX 0
- XXII 0
- Target Price
- WORX N/A
- XXII N/A
- AVG Volume (30 Days)
- WORX 8.1M
- XXII 156.2K
- Earning Date
- WORX 11-13-2025
- XXII 11-11-2025
- Dividend Yield
- WORX N/A
- XXII N/A
- EPS Growth
- WORX N/A
- XXII N/A
- EPS
- WORX N/A
- XXII N/A
- Revenue
- WORX $2,838,404.00
- XXII $21,362,000.00
- Revenue This Year
- WORX N/A
- XXII $22.41
- Revenue Next Year
- WORX N/A
- XXII $76.35
- P/E Ratio
- WORX N/A
- XXII N/A
- Revenue Growth
- WORX N/A
- XXII N/A
- 52 Week Low
- WORX $0.26
- XXII $1.59
- 52 Week High
- WORX $3.31
- XXII $1,086.75
- Technical
- Relative Strength Index (RSI)
- WORX 46.51
- XXII 28.77
- Support Level
- WORX $0.28
- XXII $1.59
- Resistance Level
- WORX $0.32
- XXII $1.86
- Average True Range (ATR)
- WORX 0.05
- XXII 0.10
- MACD
- WORX 0.00
- XXII 0.14
- Stochastic Oscillator
- WORX 8.81
- XXII 36.11
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.